National Cancer Awareness Day 2026: Early Signs, Prevention, Screening and Treatment
Nov 4, 2026
Pancreatic Cancer Awareness Month 2026 is observed throughout November to increase awareness about pancreatic cancer, encourage earlier recognition of symptoms and risk factors, support people affected by the disease, and highlight the need for continued research and improved treatment.
Pancreatic cancer is considered one of the more challenging cancers because it often causes few or no obvious symptoms in its early stages. By the time symptoms such as jaundice, persistent abdominal or back pain, unexplained weight loss or loss of appetite appear, the disease may already be more advanced.
The World Pancreatic Cancer Coalition (WPCC) is using November 2026 to encourage people worldwide to learn about pancreatic cancer symptoms and risks and to seek medical attention when something does not feel right. The campaign culminates in World Pancreatic Cancer Day on 19 November 2026.
At Metro Cancer Institute, Metro Hospital, Faridabad, patients with suspected or confirmed pancreatic cancer can access multidisciplinary evaluation through Medical Oncology, Surgical Oncology, Medical Gastroenterology and Surgical Gastroenterology. Metro Hospital’s current oncology and gastrointestinal services include management of pancreatic cancers and pancreatic surgery.
This detailed guide explains Pancreatic Cancer Awareness Month 2026, early signs and symptoms of pancreatic cancer, risk factors, diagnosis, staging, treatment options, surgery, chemotherapy, targeted therapy and when to seek specialist evaluation.
Pancreatic Cancer Awareness Month is observed throughout November 2026.
The awareness month aims to:
The World Pancreatic Cancer Coalition specifically highlights November as Pancreatic Cancer Awareness Month and uses the month to promote awareness, funding and research.
World Pancreatic Cancer Day 2026 is observed on 19 November 2026.
The 2026 campaign encourages people to understand the symptoms and risks of pancreatic cancer and to act early when concerning changes occur.
The pancreas is an organ located behind the stomach.
It performs two major functions:
The pancreas produces enzymes that help digest:
The pancreas also produces hormones such as insulin that help regulate blood sugar.
Pancreatic cancer begins when abnormal cells in the pancreas grow uncontrollably.
Most pancreatic cancers develop from the cells lining the pancreatic ducts and are classified as pancreatic adenocarcinoma.
Other, less common pancreatic tumours may arise from hormone-producing cells and are known as pancreatic neuroendocrine tumours.
One of the biggest challenges is that pancreatic cancer often does not produce obvious early symptoms.
The National Cancer Institute states that pancreatic cancer usually has no clear early signs or symptoms, making early detection difficult. Symptoms often become noticeable after the disease has progressed.
Another challenge is the pancreas’s location deep inside the abdomen.
Small tumours may not be:
This is why symptom awareness is particularly important.
Pancreatic cancer symptoms vary depending on:
Common symptoms include the following.
Jaundice is one of the most important possible warning signs.
It causes:
A pancreatic tumour located near the bile duct may block bile flow.
This causes bilirubin to build up in the bloodstream.
NCI lists jaundice among the major symptoms associated with pancreatic cancer.
Blocked bile drainage can make urine unusually dark.
Patients may describe it as:
Dark urine with jaundice should be medically evaluated promptly.
When bile does not reach the intestine normally, stool may become:
NCI identifies light-coloured stools along with jaundice and dark urine as possible pancreatic cancer symptoms.
Bile salts accumulating in the bloodstream may cause significant itching.
This may occur alongside:
Pancreatic cancer can cause pain in the:
Pain may be:
It can sometimes become worse after eating.
Pancreatic tumours may cause pain that radiates toward the back.
NCI lists pain in the upper or middle abdomen and back among typical symptoms of pancreatic cancer.
Persistent unexplained abdominal and back pain should not automatically be attributed to gas, acidity or muscular strain.
Significant weight loss without dieting can occur because cancer affects:
Unexpected weight loss is one of the most important general cancer warning signs.
Patients may notice:
Over time, this may contribute to weight loss and weakness.
A growing tumour may sometimes press on the stomach or upper intestine.
This can contribute to:
NCI includes nausea and vomiting among possible symptoms.
Some patients experience:
These symptoms are very common and usually have non-cancerous causes, but persistent unexplained bloating with weight loss or jaundice deserves assessment.
Fatigue may occur because of:
NCI includes fatigue among possible pancreatic-cancer symptoms.
One particularly important warning sign is new diabetes developing later in life without obvious risk factors.
NCI notes that new-onset diabetes in a person without typical diabetes risk factors may sometimes be an early sign of pancreatic cancer, although most people who develop diabetes do not have pancreatic cancer.
This does not mean every new diabetes diagnosis needs cancer testing.
Doctors consider:
The exact cause of most pancreatic cancers is unknown, but several risk factors are recognised.
Cigarette smoking is an important modifiable risk factor.
Stopping smoking can reduce many cancer and cardiovascular risks.
Pancreatic cancer becomes more common with increasing age.
It is less common in younger adults.
A family history of pancreatic cancer may increase risk.
People with several affected close relatives may benefit from genetic counselling.
NCI identifies family history as an established pancreatic-cancer risk factor.
Obesity is associated with increased pancreatic-cancer risk.
Maintaining a healthy weight supports general metabolic and cancer prevention.
Long-standing inflammation of the pancreas can increase risk.
NCI includes chronic pancreatitis as an established risk factor.
Certain inherited mutations can increase risk.
Examples include alterations involving:
NCI includes these genetic conditions among recognised risk factors for pancreatic cancer.
Long-standing diabetes is associated with pancreatic cancer risk.
At the same time, pancreatic cancer itself can occasionally contribute to new-onset diabetes.
There is no guaranteed way to prevent pancreatic cancer.
However, risk may potentially be reduced by:
People with significant inherited or family risk should discuss appropriate surveillance with a specialist.
Routine pancreatic-cancer screening is not recommended for average-risk adults.
Unlike breast or cervical cancer, there is no widely recommended population screening test for pancreatic cancer.
People with strong genetic or family risk may undergo specialist surveillance.
Possible tests may include:
Specialised programmes should make screening decisions.
Pancreatic cancer evaluation usually begins with:
NCI notes that imaging studies are central to diagnosing pancreatic cancer and determining whether the disease has spread.
Blood tests may evaluate:
Some patients may also have tumour marker testing.
CA 19-9 is a tumour marker that can be elevated in some pancreatic cancers.
However, it is not a reliable general screening test because it may also rise in:
Some people with pancreatic cancer may also have normal CA 19-9.
Therefore, interpret it alongside imaging and clinical findings.
A contrast-enhanced CT scan can help determine:
CT is particularly important when doctors are considering surgery.
MRI may provide detailed imaging of the:
MRCP is a specialised MRI technique used to examine the biliary and pancreatic duct systems.
Endoscopic ultrasound, or EUS, combines endoscopy with ultrasound.
It allows specialists to examine the pancreas from close range and may help obtain biopsy samples.
Metro Hospital’s Medical Gastroenterology Department offers endoscopic ultrasound as part of its diagnostic and endoscopic services.
ERCP may be used in selected patients with bile-duct obstruction.
It can:
Metro Hospital also lists ERCP among its advanced gastroenterology services.
A biopsy removes tissue so that a pathologist can confirm whether cancer cells are present.
Biopsy may be obtained using:
Modern pancreatic-cancer management increasingly includes molecular profiling.
NCI recommends molecular testing for people with pancreatic cancer because certain tumour mutations may create opportunities for targeted therapy.
Testing may identify gene changes that influence:
Genetic testing may also be recommended.
It can identify inherited cancer-risk genes and may have implications for:
Staging describes how far the cancer has spread.
Doctors often consider pancreatic cancer according to whether it is:
The tumour appears removable with surgery.
The tumour involves nearby blood vessels but may become operable after treatment.
The cancer has significant local involvement and usually cannot be removed completely with surgery initially.
The cancer has spread to distant organs.
Treatment depends heavily on these categories.
Some patients with early, surgically removable pancreatic cancer may be treated with curative intent.
However, surgery is possible only in a proportion of patients because many pancreatic cancers are diagnosed after they have already become locally advanced or metastatic.
Early diagnosis therefore matters.
When pancreatic cancer can be completely removed, surgery is generally the main treatment with curative potential.
NCI states that surgical resection remains the primary treatment modality for operable pancreatic cancer.
For cancers in the head of the pancreas, a Whipple procedure, also known as pancreaticoduodenectomy, may be performed.
It typically involves removal of:
The digestive tract is then reconstructed.
Distal pancreatectomy may treat tumours in the body or tail of the pancreas.
This removes the:
The spleen may sometimes also need removal.
In selected cases, surgeons may need to remove the entire pancreas.
Patients then require lifelong management of:
Metro Hospital’s Surgical Oncology Department lists pancreatectomy among its gastrointestinal cancer surgery procedures.
The Surgical Gastroenterology Department also provides pancreatic surgery for pancreatic cancer, pancreatitis and pancreatic cysts.
Chemotherapy may be used:
The treatment regimen depends on:
Metro Cancer Institute’s Medical Oncology Department provides chemotherapy, biological therapy, immunotherapy and targeted therapy for solid tumours including pancreatic cancer.
Neoadjuvant therapy is treatment given before surgery.
It may involve:
This can be useful in borderline-resectable pancreatic cancer.
Adjuvant treatment is given after surgery to reduce the risk of cancer returning.
NCI notes that postoperative chemotherapy improves outcomes following resection.
If molecular testing identifies specific abnormalities, targeted therapy may be an option for selected patients.
This is one reason molecular profiling has become an important part of pancreatic cancer care.
Immunotherapy has a role in a relatively small subset of pancreatic cancers with certain molecular characteristics.
It is not appropriate for every patient.
Radiation may be considered for selected patients with:
Treatment selection depends on multidisciplinary evaluation.
Metro Cancer Institute’s Radiation Oncology Department provides advanced precision radiation therapy as part of its multidisciplinary oncology programme.
Pancreatic cancer may cause significant abdominal or back pain.
Pain management may involve:
NCI notes that celiac plexus or related nerve-block procedures can provide effective pain control for selected patients.
Some pancreatic cancer patients develop difficulty digesting food because the pancreas no longer produces enough digestive enzymes.
This can cause:
Pancreatic enzyme replacement therapy may improve digestion in appropriate patients.
NCI notes that pancreatic exocrine insufficiency can contribute to malabsorption and that pancreatic enzyme replacement may help.
Nutrition is particularly important because pancreatic cancer can cause:
Nutrition plans may include:
Nutrition should be individualised to the patient’s needs.
Pancreatic cancer often requires several specialists.
These may include:
Metro Cancer Institute provides multidisciplinary cancer care integrating Medical Oncology, Surgical Oncology, Radiation Oncology and advanced diagnostics, while Metro Hospital’s gastroenterology services provide pancreatic and hepatobiliary evaluation and surgical support.
Patients with suspected pancreatic cancer can access evaluation through the Medical Gastroenterology Department.
The department provides:
For patients requiring surgery, Metro Hospital’s Surgical Gastroenterology Department manages pancreatic disorders including pancreatic cancer and provides pancreatic surgery.
Patients diagnosed with cancer can access multidisciplinary treatment through Metro Cancer Institute, including systemic cancer therapy, Surgical Oncology and Radiation Oncology.
This integrated approach helps coordinate diagnosis, staging and treatment planning within the same multispecialty care system.
Seek medical evaluation if you develop:
These symptoms do not necessarily mean pancreatic cancer, but they deserve investigation.
False.
Early pancreatic cancer may cause no symptoms at all.
False.
Jaundice can result from bile duct obstruction, including obstruction caused by a pancreatic tumour.
False.
Smoking increases risk, but pancreatic cancer can occur in people who have never smoked.
False.
Treatment options include surgery, chemotherapy, radiation therapy and targeted treatment depending on stage and molecular profile.
False.
Diabetes is extremely common, and most new cases are unrelated to pancreatic cancer. However, new-onset diabetes combined with unexplained weight loss or other suspicious symptoms may warrant further evaluation.
Pancreatic Cancer Awareness Month is observed throughout November 2026.
World Pancreatic Cancer Day 2026 is observed on 19 November 2026.
Pancreatic cancer often has no obvious early symptoms. When symptoms appear, they may include jaundice, abdominal or back pain, unexplained weight loss, poor appetite, dark urine and pale stools.
Yes. Pancreatic cancer may cause pain in the upper or middle abdomen that radiates toward the back.
New-onset diabetes can sometimes be associated with pancreatic cancer, particularly when it occurs without typical risk factors and is accompanied by unexplained weight loss.
Risk factors include smoking, obesity, chronic pancreatitis, family history and certain inherited mutations such as BRCA1, BRCA2, PALB2 and ATM.
Diagnosis may involve CT, MRI, endoscopic ultrasound, blood tests and biopsy. Doctors may also recommend molecular and genetic testing.
Some pancreatic cancers can be removed when diagnosed at a resectable stage. Surgical options may include the Whipple procedure, distal pancreatectomy or other pancreatic resections.
Not necessarily. Treatment depends on stage, surgical resectability, overall health and molecular findings. Chemotherapy is commonly used before or after surgery and for advanced disease.
Patients can seek multidisciplinary pancreatic-cancer evaluation and treatment at Metro Hospital and Metro Cancer Institute, Faridabad, through Medical Gastroenterology, Surgical Gastroenterology, Medical Oncology and Surgical Oncology.
Pancreatic Cancer Awareness Month 2026 is an important opportunity to increase awareness of a cancer that often remains difficult to detect in its early stages.
Observed throughout November, the campaign encourages people to understand pancreatic cancer symptoms and risks and to seek medical attention when unexplained changes persist.
World Pancreatic Cancer Day will be observed on 19 November 2026, with the World Pancreatic Cancer Coalition highlighting the importance of symptom awareness, earlier diagnosis and collective action.
Important warning signs include:
Pancreatic cancer treatment depends heavily on whether the tumour can be surgically removed and whether it has spread.
Modern care may involve:
At Metro Hospital, Faridabad, suspected pancreatic disease can be evaluated through the Medical Gastroenterology Department, including endoscopic ultrasound and ERCP. Pancreatic surgery is available through Surgical Gastroenterology and Surgical Oncology, while Metro Cancer Institute provides multidisciplinary oncology treatment.
The most important message this Pancreatic Cancer Awareness Month is simple:
Do not ignore unexplained jaundice, persistent abdominal or back pain, or unexplained weight loss. Early investigation may provide more treatment options.
Disclaimer: This article is intended for general health education only. Pancreatic cancer cannot be diagnosed from symptoms alone. A qualified gastroenterologist, surgeon, or oncology specialist should evaluate persistent or unexplained symptoms.